Global Specific COX-2 Inhibitors Market Research Report 2025(Status and Outlook)

March 2025 | 175 pages | ID: G2C1CDFC480DEN
Bosson Research

Abstracts

Report Overview

Specific COX-2 inhibitors are a class of medications that selectively inhibit the enzyme cyclooxygenase-2(COX-2),which is responsible for the production of prostaglandins involved in inflammation and pain response.By selectively blocking COX-2,these medications reduce inflammation and alleviate pain associated with conditions like arthritis,without significantly affecting COX-1-mediated functions in the stomach and kidneys.

This report provides a deep insight into the global Specific COX-2 Inhibitors market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Specific COX-2 Inhibitors Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Specific COX-2 Inhibitors market in any manner.

Global Specific COX-2 Inhibitors Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Organon Pharma

Pfizer

Zentiva

Neopharmed Gentili

Eskayef Pharmaceuticals

Zydus

Teva

Mylan Pharmaceutical

Actavis

Jiangsu Hengrui Pharmaceuticals

Qingdao Baheal Medical

Qilu Pharmaceutical

Shanxi Tongda Pharmaceutical

Sichuan Kelun Pharmaceutical

Jiangsu Chiatai Qingjiang Pharmaceutical

Beijing Yabao Biological Pharmaceutical

Market Segmentation (by Type)

Etoricoxib

Imrecoxib

Celecoxib

Other

Market Segmentation (by Application)

Osteoarthritis and Rheumatoid Arthritis

Dysmenorrhea

Relieve Acute Pain

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Specific COX-2 Inhibitors Market
• Overview of the regional outlook of the Specific COX-2 Inhibitors Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Specific COX-2 Inhibitors Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Specific COX-2 Inhibitors
1.2 Key Market Segments
  1.2.1 Specific COX-2 Inhibitors Segment by Type
  1.2.2 Specific COX-2 Inhibitors Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 SPECIFIC COX-2 INHIBITORS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Specific COX-2 Inhibitors Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Specific COX-2 Inhibitors Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 SPECIFIC COX-2 INHIBITORS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Specific COX-2 Inhibitors Product Life Cycle
3.3 Global Specific COX-2 Inhibitors Sales by Manufacturers (2020-2025)
3.4 Global Specific COX-2 Inhibitors Revenue Market Share by Manufacturers (2020-2025)
3.5 Specific COX-2 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Specific COX-2 Inhibitors Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Specific COX-2 Inhibitors Manufacturing Sites, Area Served, Product Type
3.8 Specific COX-2 Inhibitors Market Competitive Situation and Trends
  3.8.1 Specific COX-2 Inhibitors Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Specific COX-2 Inhibitors Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 SPECIFIC COX-2 INHIBITORS INDUSTRY CHAIN ANALYSIS

4.1 Specific COX-2 Inhibitors Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF SPECIFIC COX-2 INHIBITORS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Specific COX-2 Inhibitors Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Specific COX-2 Inhibitors Market
5.7 ESG Ratings of Leading Companies

6 SPECIFIC COX-2 INHIBITORS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Specific COX-2 Inhibitors Sales Market Share by Type (2020-2025)
6.3 Global Specific COX-2 Inhibitors Market Size Market Share by Type (2020-2025)
6.4 Global Specific COX-2 Inhibitors Price by Type (2020-2025)

7 SPECIFIC COX-2 INHIBITORS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Specific COX-2 Inhibitors Market Sales by Application (2020-2025)
7.3 Global Specific COX-2 Inhibitors Market Size (M USD) by Application (2020-2025)
7.4 Global Specific COX-2 Inhibitors Sales Growth Rate by Application (2020-2025)

8 SPECIFIC COX-2 INHIBITORS MARKET SALES BY REGION

8.1 Global Specific COX-2 Inhibitors Sales by Region
  8.1.1 Global Specific COX-2 Inhibitors Sales by Region
  8.1.2 Global Specific COX-2 Inhibitors Sales Market Share by Region
8.2 Global Specific COX-2 Inhibitors Market Size by Region
  8.2.1 Global Specific COX-2 Inhibitors Market Size by Region
  8.2.2 Global Specific COX-2 Inhibitors Market Size Market Share by Region
8.3 North America
  8.3.1 North America Specific COX-2 Inhibitors Sales by Country
  8.3.2 North America Specific COX-2 Inhibitors Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Specific COX-2 Inhibitors Sales by Country
  8.4.2 Europe Specific COX-2 Inhibitors Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Specific COX-2 Inhibitors Sales by Region
  8.5.2 Asia Pacific Specific COX-2 Inhibitors Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Specific COX-2 Inhibitors Sales by Country
  8.6.2 South America Specific COX-2 Inhibitors Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Specific COX-2 Inhibitors Sales by Region
  8.7.2 Middle East and Africa Specific COX-2 Inhibitors Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 SPECIFIC COX-2 INHIBITORS MARKET PRODUCTION BY REGION

9.1 Global Production of Specific COX-2 Inhibitors by Region(2020-2025)
9.2 Global Specific COX-2 Inhibitors Revenue Market Share by Region (2020-2025)
9.3 Global Specific COX-2 Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Specific COX-2 Inhibitors Production
  9.4.1 North America Specific COX-2 Inhibitors Production Growth Rate (2020-2025)
  9.4.2 North America Specific COX-2 Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Specific COX-2 Inhibitors Production
  9.5.1 Europe Specific COX-2 Inhibitors Production Growth Rate (2020-2025)
  9.5.2 Europe Specific COX-2 Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Specific COX-2 Inhibitors Production (2020-2025)
  9.6.1 Japan Specific COX-2 Inhibitors Production Growth Rate (2020-2025)
  9.6.2 Japan Specific COX-2 Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Specific COX-2 Inhibitors Production (2020-2025)
  9.7.1 China Specific COX-2 Inhibitors Production Growth Rate (2020-2025)
  9.7.2 China Specific COX-2 Inhibitors Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Organon Pharma
  10.1.1 Organon Pharma Basic Information
  10.1.2 Organon Pharma Specific COX-2 Inhibitors Product Overview
  10.1.3 Organon Pharma Specific COX-2 Inhibitors Product Market Performance
  10.1.4 Organon Pharma Business Overview
  10.1.5 Organon Pharma SWOT Analysis
  10.1.6 Organon Pharma Recent Developments
10.2 Pfizer
  10.2.1 Pfizer Basic Information
  10.2.2 Pfizer Specific COX-2 Inhibitors Product Overview
  10.2.3 Pfizer Specific COX-2 Inhibitors Product Market Performance
  10.2.4 Pfizer Business Overview
  10.2.5 Pfizer SWOT Analysis
  10.2.6 Pfizer Recent Developments
10.3 Zentiva
  10.3.1 Zentiva Basic Information
  10.3.2 Zentiva Specific COX-2 Inhibitors Product Overview
  10.3.3 Zentiva Specific COX-2 Inhibitors Product Market Performance
  10.3.4 Zentiva Business Overview
  10.3.5 Zentiva SWOT Analysis
  10.3.6 Zentiva Recent Developments
10.4 Neopharmed Gentili
  10.4.1 Neopharmed Gentili Basic Information
  10.4.2 Neopharmed Gentili Specific COX-2 Inhibitors Product Overview
  10.4.3 Neopharmed Gentili Specific COX-2 Inhibitors Product Market Performance
  10.4.4 Neopharmed Gentili Business Overview
  10.4.5 Neopharmed Gentili Recent Developments
10.5 Eskayef Pharmaceuticals
  10.5.1 Eskayef Pharmaceuticals Basic Information
  10.5.2 Eskayef Pharmaceuticals Specific COX-2 Inhibitors Product Overview
  10.5.3 Eskayef Pharmaceuticals Specific COX-2 Inhibitors Product Market Performance
  10.5.4 Eskayef Pharmaceuticals Business Overview
  10.5.5 Eskayef Pharmaceuticals Recent Developments
10.6 Zydus
  10.6.1 Zydus Basic Information
  10.6.2 Zydus Specific COX-2 Inhibitors Product Overview
  10.6.3 Zydus Specific COX-2 Inhibitors Product Market Performance
  10.6.4 Zydus Business Overview
  10.6.5 Zydus Recent Developments
10.7 Teva
  10.7.1 Teva Basic Information
  10.7.2 Teva Specific COX-2 Inhibitors Product Overview
  10.7.3 Teva Specific COX-2 Inhibitors Product Market Performance
  10.7.4 Teva Business Overview
  10.7.5 Teva Recent Developments
10.8 Mylan Pharmaceutical
  10.8.1 Mylan Pharmaceutical Basic Information
  10.8.2 Mylan Pharmaceutical Specific COX-2 Inhibitors Product Overview
  10.8.3 Mylan Pharmaceutical Specific COX-2 Inhibitors Product Market Performance
  10.8.4 Mylan Pharmaceutical Business Overview
  10.8.5 Mylan Pharmaceutical Recent Developments
10.9 Actavis
  10.9.1 Actavis Basic Information
  10.9.2 Actavis Specific COX-2 Inhibitors Product Overview
  10.9.3 Actavis Specific COX-2 Inhibitors Product Market Performance
  10.9.4 Actavis Business Overview
  10.9.5 Actavis Recent Developments
10.10 Jiangsu Hengrui Pharmaceuticals
  10.10.1 Jiangsu Hengrui Pharmaceuticals Basic Information
  10.10.2 Jiangsu Hengrui Pharmaceuticals Specific COX-2 Inhibitors Product Overview
  10.10.3 Jiangsu Hengrui Pharmaceuticals Specific COX-2 Inhibitors Product Market Performance
  10.10.4 Jiangsu Hengrui Pharmaceuticals Business Overview
  10.10.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
10.11 Qingdao Baheal Medical
  10.11.1 Qingdao Baheal Medical Basic Information
  10.11.2 Qingdao Baheal Medical Specific COX-2 Inhibitors Product Overview
  10.11.3 Qingdao Baheal Medical Specific COX-2 Inhibitors Product Market Performance
  10.11.4 Qingdao Baheal Medical Business Overview
  10.11.5 Qingdao Baheal Medical Recent Developments
10.12 Qilu Pharmaceutical
  10.12.1 Qilu Pharmaceutical Basic Information
  10.12.2 Qilu Pharmaceutical Specific COX-2 Inhibitors Product Overview
  10.12.3 Qilu Pharmaceutical Specific COX-2 Inhibitors Product Market Performance
  10.12.4 Qilu Pharmaceutical Business Overview
  10.12.5 Qilu Pharmaceutical Recent Developments
10.13 Shanxi Tongda Pharmaceutical
  10.13.1 Shanxi Tongda Pharmaceutical Basic Information
  10.13.2 Shanxi Tongda Pharmaceutical Specific COX-2 Inhibitors Product Overview
  10.13.3 Shanxi Tongda Pharmaceutical Specific COX-2 Inhibitors Product Market Performance
  10.13.4 Shanxi Tongda Pharmaceutical Business Overview
  10.13.5 Shanxi Tongda Pharmaceutical Recent Developments
10.14 Sichuan Kelun Pharmaceutical
  10.14.1 Sichuan Kelun Pharmaceutical Basic Information
  10.14.2 Sichuan Kelun Pharmaceutical Specific COX-2 Inhibitors Product Overview
  10.14.3 Sichuan Kelun Pharmaceutical Specific COX-2 Inhibitors Product Market Performance
  10.14.4 Sichuan Kelun Pharmaceutical Business Overview
  10.14.5 Sichuan Kelun Pharmaceutical Recent Developments
10.15 Jiangsu Chiatai Qingjiang Pharmaceutical
  10.15.1 Jiangsu Chiatai Qingjiang Pharmaceutical Basic Information
  10.15.2 Jiangsu Chiatai Qingjiang Pharmaceutical Specific COX-2 Inhibitors Product Overview
  10.15.3 Jiangsu Chiatai Qingjiang Pharmaceutical Specific COX-2 Inhibitors Product Market Performance
  10.15.4 Jiangsu Chiatai Qingjiang Pharmaceutical Business Overview
  10.15.5 Jiangsu Chiatai Qingjiang Pharmaceutical Recent Developments
10.16 Beijing Yabao Biological Pharmaceutical
  10.16.1 Beijing Yabao Biological Pharmaceutical Basic Information
  10.16.2 Beijing Yabao Biological Pharmaceutical Specific COX-2 Inhibitors Product Overview
  10.16.3 Beijing Yabao Biological Pharmaceutical Specific COX-2 Inhibitors Product Market Performance
  10.16.4 Beijing Yabao Biological Pharmaceutical Business Overview
  10.16.5 Beijing Yabao Biological Pharmaceutical Recent Developments

11 SPECIFIC COX-2 INHIBITORS MARKET FORECAST BY REGION

11.1 Global Specific COX-2 Inhibitors Market Size Forecast
11.2 Global Specific COX-2 Inhibitors Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Specific COX-2 Inhibitors Market Size Forecast by Country
  11.2.3 Asia Pacific Specific COX-2 Inhibitors Market Size Forecast by Region
  11.2.4 South America Specific COX-2 Inhibitors Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Specific COX-2 Inhibitors by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Specific COX-2 Inhibitors Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Specific COX-2 Inhibitors by Type (2026-2033)
  12.1.2 Global Specific COX-2 Inhibitors Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Specific COX-2 Inhibitors by Type (2026-2033)
12.2 Global Specific COX-2 Inhibitors Market Forecast by Application (2026-2033)
  12.2.1 Global Specific COX-2 Inhibitors Sales (K MT) Forecast by Application
  12.2.2 Global Specific COX-2 Inhibitors Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Specific COX-2 Inhibitors Market Size Comparison by Region (M USD)
Table 5. Global Specific COX-2 Inhibitors Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Specific COX-2 Inhibitors Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Specific COX-2 Inhibitors Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Specific COX-2 Inhibitors Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specific COX-2 Inhibitors as of 2024)
Table 10. Global Market Specific COX-2 Inhibitors Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Specific COX-2 Inhibitors Manufacturing Sites and Area Served
Table 12. Manufacturers Specific COX-2 Inhibitors Product Type
Table 13. Global Specific COX-2 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Specific COX-2 Inhibitors Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Specific COX-2 Inhibitors Sales by Type (K MT)
Table 25. Global Specific COX-2 Inhibitors Market Size by Type (M USD)
Table 26. Global Specific COX-2 Inhibitors Sales (K MT) by Type (2020-2025)
Table 27. Global Specific COX-2 Inhibitors Sales Market Share by Type (2020-2025)
Table 28. Global Specific COX-2 Inhibitors Market Size (M USD) by Type (2020-2025)
Table 29. Global Specific COX-2 Inhibitors Market Size Share by Type (2020-2025)
Table 30. Global Specific COX-2 Inhibitors Price (USD/MT) by Type (2020-2025)
Table 31. Global Specific COX-2 Inhibitors Sales (K MT) by Application
Table 32. Global Specific COX-2 Inhibitors Market Size by Application
Table 33. Global Specific COX-2 Inhibitors Sales by Application (2020-2025) & (K MT)
Table 34. Global Specific COX-2 Inhibitors Sales Market Share by Application (2020-2025)
Table 35. Global Specific COX-2 Inhibitors Market Size by Application (2020-2025) & (M USD)
Table 36. Global Specific COX-2 Inhibitors Market Share by Application (2020-2025)
Table 37. Global Specific COX-2 Inhibitors Sales Growth Rate by Application (2020-2025)
Table 38. Global Specific COX-2 Inhibitors Sales by Region (2020-2025) & (K MT)
Table 39. Global Specific COX-2 Inhibitors Sales Market Share by Region (2020-2025)
Table 40. Global Specific COX-2 Inhibitors Market Size by Region (2020-2025) & (M USD)
Table 41. Global Specific COX-2 Inhibitors Market Size Market Share by Region (2020-2025)
Table 42. North America Specific COX-2 Inhibitors Sales by Country (2020-2025) & (K MT)
Table 43. North America Specific COX-2 Inhibitors Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Specific COX-2 Inhibitors Sales by Country (2020-2025) & (K MT)
Table 45. Europe Specific COX-2 Inhibitors Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Specific COX-2 Inhibitors Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Specific COX-2 Inhibitors Market Size by Region (2020-2025) & (M USD)
Table 48. South America Specific COX-2 Inhibitors Sales by Country (2020-2025) & (K MT)
Table 49. South America Specific COX-2 Inhibitors Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Specific COX-2 Inhibitors Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Specific COX-2 Inhibitors Market Size by Region (2020-2025) & (M USD)
Table 52. Global Specific COX-2 Inhibitors Production (K MT) by Region(2020-2025)
Table 53. Global Specific COX-2 Inhibitors Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Specific COX-2 Inhibitors Revenue Market Share by Region (2020-2025)
Table 55. Global Specific COX-2 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Specific COX-2 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Specific COX-2 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Specific COX-2 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Specific COX-2 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Organon Pharma Basic Information
Table 61. Organon Pharma Specific COX-2 Inhibitors Product Overview
Table 62. Organon Pharma Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Organon Pharma Business Overview
Table 64. Organon Pharma SWOT Analysis
Table 65. Organon Pharma Recent Developments
Table 66. Pfizer Basic Information
Table 67. Pfizer Specific COX-2 Inhibitors Product Overview
Table 68. Pfizer Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. Pfizer Business Overview
Table 70. Pfizer SWOT Analysis
Table 71. Pfizer Recent Developments
Table 72. Zentiva Basic Information
Table 73. Zentiva Specific COX-2 Inhibitors Product Overview
Table 74. Zentiva Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Zentiva Business Overview
Table 76. Zentiva SWOT Analysis
Table 77. Zentiva Recent Developments
Table 78. Neopharmed Gentili Basic Information
Table 79. Neopharmed Gentili Specific COX-2 Inhibitors Product Overview
Table 80. Neopharmed Gentili Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Neopharmed Gentili Business Overview
Table 82. Neopharmed Gentili Recent Developments
Table 83. Eskayef Pharmaceuticals Basic Information
Table 84. Eskayef Pharmaceuticals Specific COX-2 Inhibitors Product Overview
Table 85. Eskayef Pharmaceuticals Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Eskayef Pharmaceuticals Business Overview
Table 87. Eskayef Pharmaceuticals Recent Developments
Table 88. Zydus Basic Information
Table 89. Zydus Specific COX-2 Inhibitors Product Overview
Table 90. Zydus Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Zydus Business Overview
Table 92. Zydus Recent Developments
Table 93. Teva Basic Information
Table 94. Teva Specific COX-2 Inhibitors Product Overview
Table 95. Teva Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Teva Business Overview
Table 97. Teva Recent Developments
Table 98. Mylan Pharmaceutical Basic Information
Table 99. Mylan Pharmaceutical Specific COX-2 Inhibitors Product Overview
Table 100. Mylan Pharmaceutical Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Mylan Pharmaceutical Business Overview
Table 102. Mylan Pharmaceutical Recent Developments
Table 103. Actavis Basic Information
Table 104. Actavis Specific COX-2 Inhibitors Product Overview
Table 105. Actavis Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Actavis Business Overview
Table 107. Actavis Recent Developments
Table 108. Jiangsu Hengrui Pharmaceuticals Basic Information
Table 109. Jiangsu Hengrui Pharmaceuticals Specific COX-2 Inhibitors Product Overview
Table 110. Jiangsu Hengrui Pharmaceuticals Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 112. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 113. Qingdao Baheal Medical Basic Information
Table 114. Qingdao Baheal Medical Specific COX-2 Inhibitors Product Overview
Table 115. Qingdao Baheal Medical Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Qingdao Baheal Medical Business Overview
Table 117. Qingdao Baheal Medical Recent Developments
Table 118. Qilu Pharmaceutical Basic Information
Table 119. Qilu Pharmaceutical Specific COX-2 Inhibitors Product Overview
Table 120. Qilu Pharmaceutical Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Qilu Pharmaceutical Business Overview
Table 122. Qilu Pharmaceutical Recent Developments
Table 123. Shanxi Tongda Pharmaceutical Basic Information
Table 124. Shanxi Tongda Pharmaceutical Specific COX-2 Inhibitors Product Overview
Table 125. Shanxi Tongda Pharmaceutical Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 126. Shanxi Tongda Pharmaceutical Business Overview
Table 127. Shanxi Tongda Pharmaceutical Recent Developments
Table 128. Sichuan Kelun Pharmaceutical Basic Information
Table 129. Sichuan Kelun Pharmaceutical Specific COX-2 Inhibitors Product Overview
Table 130. Sichuan Kelun Pharmaceutical Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 131. Sichuan Kelun Pharmaceutical Business Overview
Table 132. Sichuan Kelun Pharmaceutical Recent Developments
Table 133. Jiangsu Chiatai Qingjiang Pharmaceutical Basic Information
Table 134. Jiangsu Chiatai Qingjiang Pharmaceutical Specific COX-2 Inhibitors Product Overview
Table 135. Jiangsu Chiatai Qingjiang Pharmaceutical Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 136. Jiangsu Chiatai Qingjiang Pharmaceutical Business Overview
Table 137. Jiangsu Chiatai Qingjiang Pharmaceutical Recent Developments
Table 138. Beijing Yabao Biological Pharmaceutical Basic Information
Table 139. Beijing Yabao Biological Pharmaceutical Specific COX-2 Inhibitors Product Overview
Table 140. Beijing Yabao Biological Pharmaceutical Specific COX-2 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 141. Beijing Yabao Biological Pharmaceutical Business Overview
Table 142. Beijing Yabao Biological Pharmaceutical Recent Developments
Table 143. Global Specific COX-2 Inhibitors Sales Forecast by Region (2026-2033) & (K MT)
Table 144. Global Specific COX-2 Inhibitors Market Size Forecast by Region (2026-2033) & (M USD)
Table 145. North America Specific COX-2 Inhibitors Sales Forecast by Country (2026-2033) & (K MT)
Table 146. North America Specific COX-2 Inhibitors Market Size Forecast by Country (2026-2033) & (M USD)
Table 147. Europe Specific COX-2 Inhibitors Sales Forecast by Country (2026-2033) & (K MT)
Table 148. Europe Specific COX-2 Inhibitors Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Asia Pacific Specific COX-2 Inhibitors Sales Forecast by Region (2026-2033) & (K MT)
Table 150. Asia Pacific Specific COX-2 Inhibitors Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. South America Specific COX-2 Inhibitors Sales Forecast by Country (2026-2033) & (K MT)
Table 152. South America Specific COX-2 Inhibitors Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Middle East and Africa Specific COX-2 Inhibitors Sales Forecast by Country (2026-2033) & (Units)
Table 154. Middle East and Africa Specific COX-2 Inhibitors Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Global Specific COX-2 Inhibitors Sales Forecast by Type (2026-2033) & (K MT)
Table 156. Global Specific COX-2 Inhibitors Market Size Forecast by Type (2026-2033) & (M USD)
Table 157. Global Specific COX-2 Inhibitors Price Forecast by Type (2026-2033) & (USD/MT)
Table 158. Global Specific COX-2 Inhibitors Sales (K MT) Forecast by Application (2026-2033)
Table 159. Global Specific COX-2 Inhibitors Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Specific COX-2 Inhibitors
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Specific COX-2 Inhibitors Market Size (M USD), 2024-2033
Figure 5. Global Specific COX-2 Inhibitors Market Size (M USD) (2020-2033)
Figure 6. Global Specific COX-2 Inhibitors Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Specific COX-2 Inhibitors Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Specific COX-2 Inhibitors Product Life Cycle
Figure 13. Specific COX-2 Inhibitors Sales Share by Manufacturers in 2024
Figure 14. Global Specific COX-2 Inhibitors Revenue Share by Manufacturers in 2024
Figure 15. Specific COX-2 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Specific COX-2 Inhibitors Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Specific COX-2 Inhibitors Revenue in 2024
Figure 18. Industry Chain Map of Specific COX-2 Inhibitors
Figure 19. Global Specific COX-2 Inhibitors Market PEST Analysis
Figure 20. Global Specific COX-2 Inhibitors Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Specific COX-2 Inhibitors Market Share by Type
Figure 27. Sales Market Share of Specific COX-2 Inhibitors by Type (2020-2025)
Figure 28. Sales Market Share of Specific COX-2 Inhibitors by Type in 2024
Figure 29. Market Size Share of Specific COX-2 Inhibitors by Type (2020-2025)
Figure 30. Market Size Share of Specific COX-2 Inhibitors by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Specific COX-2 Inhibitors Market Share by Application
Figure 33. Global Specific COX-2 Inhibitors Sales Market Share by Application (2020-2025)
Figure 34. Global Specific COX-2 Inhibitors Sales Market Share by Application in 2024
Figure 35. Global Specific COX-2 Inhibitors Market Share by Application (2020-2025)
Figure 36. Global Specific COX-2 Inhibitors Market Share by Application in 2024
Figure 37. Global Specific COX-2 Inhibitors Sales Growth Rate by Application (2020-2025)
Figure 38. Global Specific COX-2 Inhibitors Sales Market Share by Region (2020-2025)
Figure 39. Global Specific COX-2 Inhibitors Market Size Market Share by Region (2020-2025)
Figure 40. North America Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Specific COX-2 Inhibitors Sales Market Share by Country in 2024
Figure 43. North America Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Specific COX-2 Inhibitors Market Size Market Share by Country in 2024
Figure 45. U.S. Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Specific COX-2 Inhibitors Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Specific COX-2 Inhibitors Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Specific COX-2 Inhibitors Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Specific COX-2 Inhibitors Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Specific COX-2 Inhibitors Sales Market Share by Country in 2024
Figure 53. Europe Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Specific COX-2 Inhibitors Market Size Market Share by Country in 2024
Figure 55. Germany Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Specific COX-2 Inhibitors Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Specific COX-2 Inhibitors Sales Market Share by Region in 2024
Figure 67. Asia Pacific Specific COX-2 Inhibitors Market Size Market Share by Region in 2024
Figure 68. China Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Specific COX-2 Inhibitors Sales and Growth Rate (K MT)
Figure 79. South America Specific COX-2 Inhibitors Sales Market Share by Country in 2024
Figure 80. South America Specific COX-2 Inhibitors Market Size and Growth Rate (M USD)
Figure 81. South America Specific COX-2 Inhibitors Market Size Market Share by Country in 2024
Figure 82. Brazil Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Specific COX-2 Inhibitors Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Specific COX-2 Inhibitors Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Specific COX-2 Inhibitors Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Specific COX-2 Inhibitors Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Specific COX-2 Inhibitors Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Specific COX-2 Inhibitors Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Specific COX-2 Inhibitors Production Market Share by Region (2020-2025)
Figure 103. North America Specific COX-2 Inhibitors Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Specific COX-2 Inhibitors Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Specific COX-2 Inhibitors Production (K MT) Growth Rate (2020-2025)
Figure 106. China Specific COX-2 Inhibitors Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Specific COX-2 Inhibitors Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Specific COX-2 Inhibitors Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Specific COX-2 Inhibitors Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Specific COX-2 Inhibitors Market Share Forecast by Type (2026-2033)
Figure 111. Global Specific COX-2 Inhibitors Sales Forecast by Application (2026-2033)
Figure 112. Global Specific COX-2 Inhibitors Market Share Forecast by Application (2026-2033)